ClinicalTrials.gg
RecruitingNCT06459661BoMoMoUpdated Jun 17, 2024

The Bowel Movement Monitoring (BoMoMo) Study

An observational study in Dietary Exposure, sponsored by Leeds Beckett University. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-17.

Sponsored by Leeds Beckett University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
24
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The link between what people eat and how it affects faecal output (poo) has been understudied. Most of the research that has looked at the link between diet, bowel movements and overall health has studied different types of fibre extracted from foods (e.g., fibre extracted from carrots), rather than foods in the form that they are consumed.

It is necessary for scientists to investigate the relationship between food as people usual eat it (e.g., a carrot) and bowel movements, as this information is key to understanding the relationship between what people eat and overall health.

The investigators would like to understand the relationship between intake of certain foods and faecal output. This will help to develop a chart, similar to the United Kingdom National Health Service urine colour hydration chart. The chart will allow people to know, by looking at their poo, whether they are eating enough of the foods that will keep them healthy. By monitoring and measuring participants' bowel movements, and providing information about diet, participants will provide the data we need for this research.

Read the detailed description

Participants will complete a 5-day estimated food record and weigh, characterise and photograph each stool for 5 days.

02

Conditions studied

  • Dietary Exposure
03

In context

Lead sponsor

Leeds Beckett University is the lead sponsor of 10 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy adults

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 18-60 years.
  • Healthy as determined from self-reported medical history or when no relevant medical condition exists.
  • Stool frequency of 3 to 21 times per week.
  • Able to attend a session in person at City Campus or Headingley Campus, Leeds Beckett University, or City Campus, Sheffield Hallam University.
  • For women: Use of methods or not planning to become pregnant for the duration of the study.
  • Able to understand and be willing to sign the form, and to follow all the study procedures and requirements.

Exclusion criteria

Exclusion Criteria:

  • Food allergy or intolerance
  • Currently dieting to lose weight
  • For women: Pregnancy, lactation
  • Bowel disease
  • Use of medicine causing constipation
  • Abnormal gastro-intestinal (gut) function or structure such as malformation, angiodysplasia or active peptic ulcer
  • History of gastro-intestinal surgery with permanent effect (e.g., surgical treatment of obesity)
  • Active inflammatory bowel disease, coeliac disease, chronic pancreatitis, or other disorder potentially causing malabsorption
  • Currently experiencing or been diagnosed with gastro-intestinal symptoms (e.g., abdominal pain/cramps, heartburn, stomach acid/reflux, nausea, vomiting, abdominal rumbling, bloating, belching, excess gas/wind)
  • Active constipation (i.e., currently constipated).
  • Active Irritable Bowel Syndrome
  • Currently experiencing disordered eating
  • Current use of laxatives
  • Current use or within the previous 3 months use of prescription or over-the-counter medication that has the potential of affecting gut bacteria including food supplements (specific medications will be assessed on an individual basis).
  • Use of antibiotics or pain medication containing opiates or morphine currently or within the previous 3 months.
  • Use of opioid drugs of abuse (e.g., heroin, fentanyl) currently or within the previous 3 months.
  • Consumption of more than 21 units of alcohol per week (men)/ more than 14 unit of alcohol per week (women).
  • /cancer which is currently active or in remission for less than 2 years after treatment.
  • Currently experiencing a psychiatric disorder or a condition related with your mental health that impacts on your daily life (e.g., major depression, bipolar disorders).
  • Currently engaging in intense physical activity more than 3 times per week (assessed on an individual basis).
  • Presenting a psychological or linguistic incapability to sign the / Investigator considers the subject unlikely to comply with study procedures, restrictions, and requirements.
  • Parallel participation in another research project which involves dietary intervention/other clinical trial.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
24 participants (estimated)
Patient registry
No

Interventions

  • OtherDiet

    Intake of unrefined, intact plant foods

06

What researchers measure

Primary outcomes

  1. Faecal weight

    Average weight of faeces

    Time frame: 5 days

Secondary outcomes

  1. Faecal bulk

    Volume of faeces

    Time frame: 5 Days

Other outcomes

  1. Time to pass stool

    Number of seconds taken to pass stool

    Time frame: 5 Days

  2. Stool type

    Average Bristol Stool Form Scale type (Type 1-7 nominal scale; types 3,4,5 are considered the 'normal range')

    Time frame: 5 Days

07

Study locations

1 of 1 sites recruiting
  • Beverley O'Hara
    Leeds, LS1 3HE, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2024 (actual). Primary completion is estimated for Jun 2024, 1 month after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2024
First posted
Jun 14, 2024
StartActual
May 1, 2024
Primary completionEst.
Jun 30, 2024
CompletionEst.
Jun 30, 2024
Last update
Jun 17, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06459661
Lead sponsor
Leeds Beckett University
Responsible party
Beverley O'Hara (Lecturer (Nutrition), Leeds Beckett University) — Principal investigator
First posted
Jun 14, 2024
Start date
May 1, 2024
Primary completion
Jun 30, 2024 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Jun 17, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion